Patent US4528186A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4528186A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of producing human epidermal growth factor

Assignee: Japan Chemical Research Co Ltd
•
Filing: 1983-06-09
•
Granted: 1985-07-09
•
Expires: 2003-06-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for producing a human epidermal growth factor in high yield and high purity by adding particles of an aluminum or magnesium silicate of the formula z.2 (or 6) SiO 2 .xH 2 O where Z is Al 2 O 3 or 2MgO and x is the number of water molecules in each molecule of the compound, to human urine under neutral to acid conditions to adsorb the factor on the particles and then eluting the factor with an alkaline solution.

Inventors

  • 👤 Toyohiko Nishimura
  • 👤 Naomi Uchida
  • 👤 Hajime Hiratani

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 15:19
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/475; C07K14/485; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/834

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 144 words
In a method of producing a human epidermal growth factor from human urine wherein said urine is contacted with a hydrous aluminum silicate and wherein said epidermal growth factor is adsorbed on said hydrous aluminum silicate and subsequently eluted therefrom with an alkaline solution, the improvement which comprises the steps of: (a) pretreating said urine to precipitate impurities by adjusting the pH to about 8-9 and separating said impurities, (b) adding particles of an aluminum or magnesium silicate of the formula: Z.2(or 6)SiO.sub.2 xH.sub.2 O wherein Z is Al 2 O 3 or 2MgO; x is the number of water molecules in each molecule of the compound as governed by the water content of the compound, to said urine under neutral to acid conditions to thereby adsorb said factor on said particles and, (c) eluting said factor from said particles with an alkaline solution.
Claim 2
Dependent Claim 144 words
In a method of producing a human epidermal growth factor from human urine wherein said urine is contacted with a hydrous aluminum silicate and wherein said epidermal growth factor is adsorbed on said hydrous aluminum silicate and subsequently eluted therefrom with an alkaline solution, the improvement which comprises the steps of: (a) pretreating said urine to precipitate impurities by adjusting the pH to about 8-9 and separating said impurities, (b) adding particles of an aluminum or magnesium silicate of the formula: Z.2(or 6)SiO.sub.2 xH.sub.2 O wherein Z is Al 2 O 3 or 2MgO; x is the number of water molecules in each molecule of the compound as governed by the water content of the compound, to said urine under neutral to acid conditions to thereby adsorb said factor on said particles and, (c) eluting said factor from said particles with an alkaline solution.
Claim 3
Dependent Claim 41 words
A method as set forth in claim 1 wherein the aluminiumsilicate used for adsorbing the active factor in human urine is represented by the formula: Al 2 O 3 .2(or 6)-SiO 2 .xH 2 O, wherein x is as defined above.
Claim 4
Dependent Claim 35 words
A method as set forth in claim 1 wherein the magnesium silicate used for adsorbing the active factor in human urine is a compound of the formula: 2MgO.6SiO.sub.2.xH.sub.2 O, wherein x is as defined above.
Claim 5
Dependent Claim 18 words
The method of claim 1 wherein said factor is eluted from said particles at a pH of 10-12.
Claim 6
Dependent Claim 59 words
A method as set forth in claim 1 wherein said human urine has been previously purified by adding particles of aluminiumsilicate of the formula: Al 2 O 3 .9SiO 2 .xH 2 O, wherein x is as defined above, silicic acid or aluminum hydroxide to fresh human urine to thereby adsorb impurities on said particles and removing the particles.
Claim 7
Dependent Claim 65 words
A method as set forth in claim 5 wherein impurities in human urine are adsorbed by adding to the urine an aluminumsilicate of the formula: Al 2 O 3 .9SiO 2 .xH 2 O under weakly acidic conditions and at a pH 3 to 5, or a silicic acid under weakly acidic conditions at a pH 4 to 6, or aluminum hydroxide under neutral conditions.
Claim 8
Dependent Claim 42 words
A method as set forth in claim 5 wherein said silicic acid is represented by the formula ySiO 2 .xH 2 O, wherein x is as defined above; y is the number of silicon oxide molecules in each molecule of the compound.
Claim 9
Dependent Claim 22 words
A method as set forth in claim 5 wherein said aluminum hydroxide is represented by the formula Al 2 (OH) 3 .

References Cited (Backward Citations)

JPS5167229A Cited
SU537681A1 Cited
JPS6025112A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-07-08 1989-01-07 1989-07-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-07-08 1993-01-07 1993-07-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-07-08 1997-01-07 1997-07-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag